Projects per year
Fenretinide is a pro-apoptotic, cytotoxic, synthetic Vitamin A analogue with application in the treatment of Ewing’s sarcoma. For pediatric study, a ‘cookie dough’ formulation had been developed, improving upon an existing corn oil formulation. We report on a simplified capsular formulation of Fenretinide with the novel solubility and bioavailability enhancing lipid matrix, Lym-X-Sorb™.
|Publication status||Published - 3 Sept 2010|
|Event||UK-PharmSci 2010 – The Science of Medicines - Nottingham, United Kingdom|
Duration: 1 Sept 2010 → 3 Sept 2010
|Conference||UK-PharmSci 2010 – The Science of Medicines|
|Period||1/09/10 → 3/09/10|
FingerprintDive into the research topics of 'Experiences of melt fi ll production of Fenretinide/Lym-X-Sorb™ hard gelatin capsules for Phase I clinical trial'. Together they form a unique fingerprint.
- 1 Finished
Cancer Research UK Formulation Unit 2007/2008
1/10/07 → 31/03/10